Home
Who We Are
Our Science
Clinical Trials
Our Community
Contact Us
Menu
Home
Who We Are
Our Science
Clinical Trials
Our Community
Contact Us
Inspired by Patients to Improve Outcomes in Systemic Sclerosis
OUR SCIENCE
Our focus on Prostacyclin analogues is based on research establishing PGI2 as a potent vasodilator with antiplatelet, antiproliferative and anti-inflammatory properties
LEARN MORE >>
CLINICAL TRIALS
AURORA is a Phase 3 clinical trial evaluating the efficacy and safety of Intravenous iloprost in Systemic Sclerosis
LEARN MORE >>
OUR COMMUNITY
We are committed to enriching the lives of Systemic Sclerosis patients through research and education
LEARN MORE >>